Literature DB >> 16936172

Use of U-500 regular insulin in type 2 diabetes.

Wafic S Wafa, Mukhtar I Khan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16936172     DOI： 10.2337/dc06-1148

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  8 in total

1.  U-500 insulin as a component of basal bolus insulin therapy in type 2 diabetes.

Authors:  Jolene Brown Lowery; Amy C Donihi; Mary T Korytkowski
Journal:  Diabetes Technol Ther       Date:  2012-02-24       Impact factor: 6.118

Review 2.  Clinical use of U-500 regular insulin: review and meta-analysis.

Authors:  Sirimon Reutrakul; Kristen Wroblewski; Rebecca L Brown
Journal:  J Diabetes Sci Technol       Date:  2012-03-01

Review 3.  Extreme insulin resistance: indications and approaches to the use of U-500 insulin in type 2 diabetes mellitus.

Authors:  Alexandria M Dailey; Lisa R Tannock
Journal:  Curr Diab Rep       Date:  2011-04       Impact factor: 4.810

4.  Durability of glycemic control using U-500 insulin.

Authors:  Alexandria M Dailey; Jennifer A Gibert; Lisa R Tannock
Journal:  Diabetes Res Clin Pract       Date:  2011-11-15       Impact factor: 5.602

5.  Clinical efficacy and patient satisfaction with U-500 insulin use.

Authors:  Alexandria M Dailey; Sarah Williams; Deepa Taneja; Lisa R Tannock
Journal:  Diabetes Res Clin Pract       Date:  2010-03-11       Impact factor: 5.602

6.  Application of PK/PD modeling and simulation to dosing regimen optimization of high-dose human regular U-500 insulin.

Authors:  Amparo de la Peña; Xiaosu Ma; Shobha Reddy; Fernando Ovalle; Richard M Bergenstal; Jeffrey A Jackson
Journal:  J Diabetes Sci Technol       Date:  2014-05-12

Review 7.  Insulin therapy for type 2 diabetes.

Authors:  Luigi F Meneghini
Journal:  Endocrine       Date:  2012-10-27       Impact factor: 3.633

8.  Treatment Approach to Patients With Severe Insulin Resistance.

Authors:  Timothy J Church; Stuart T Haines
Journal:  Clin Diabetes       Date:  2016-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.